We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
(+177%)
Cap. Flow
+$4.13B
Cap. Flow
% of AUM
61.82%
Top 10 Holdings %
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teleflex
TFX
|
+$84.6M |
| 2 |
McDonald's
MCD
|
+$79.3M |
| 3 |
Best Buy
BBY
|
+$78M |
| 4 |
S&P Global
SPGI
|
+$75.1M |
| 5 |
Quest Diagnostics
DGX
|
+$73.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$79.1M |
| 2 |
MON
Monsanto Co
MON
|
+$59.9M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$44M |
| 4 |
ABLX
Ablynx NV
ABLX
|
+$38.8M |
| 5 |
Liberty Global Class C
LBTYK
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.81% |
| 2 | Healthcare | 17.75% |
| 3 | Technology | 12.65% |
| 4 | Financials | 8.92% |
| 5 | Consumer Staples | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
AstraZeneca
AZN
$263B
| $10.5M | 0.16% |
+149,796
| New | +$10.8M |
|
|
VMW
177
DELISTED
VMware, Inc
VMW
| $10.4M | 0.16% |
+70,866
| New | +$9.77M |
|
|
HRC
178
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $10.4M | 0.16% |
+118,988
| New | +$10.6M |
|
|
TSE
179
DELISTED
Trinseo
TSE
| $10.4M | 0.16% |
146,274
+138,942
| +1,895% | +$10.3M |
|
180
Dick's Sporting Goods
DKS
$18.4B
| $10.3M | 0.15% |
292,447
+284,560
| +3,608% | +$9.66M |
|
|
MDR
181
DELISTED
McDermott International
MDR
| $10.3M | 0.15% |
+522,057
| New | +$10.6M |
|
182
UBS Group
UBS
$170B
| $10.1M | 0.15% |
655,873
+631,861
| +2,631% | +$10.3M |
|
183
Raymond James Financial
RJF
$32.5B
| $10M | 0.15% |
+167,840
| New | +$10.4M |
|
184
Bread Financial
BFH
$4.21B
| $9.97M | 0.15% |
+53,582
| New | +$9.15M |
|
185
Progress Software
PRGS
$1.55B
| $9.9M | 0.15% |
+255,000
| New | +$9.68M |
|
|
OPTU
186
Optimum Communications Inc
OPTU
$316M
| $9.88M | 0.15% |
+578,915
| New | +$10.7M |
|
|
VXX
187
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $9.72M | 0.15% |
262,586
+120,705
| +85% | +$4.67M |
|
|
ZAYO
188
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $9.57M | 0.14% |
+262,440
| New | +$9.35M |
|
189
CVS Health
CVS
$137B
| $9.2M | 0.14% |
+142,906
| New | +$9.42M |
|
|
CMBT
190
CMB.TECH NV
CMBT
$4.57B
| $9.08M | 0.14% |
987,658
+935,077
| +1,778% | +$8.2M |
|
191
Universal Health Services
UHS
$9.43B
| $9.07M | 0.14% |
81,357
+66,012
| +430% | +$7.73M |
|
|
EAGLU
192
DELISTED
Platinum Eagle Acquisition Corp. Unit
EAGLU
| $9.04M | 0.14% |
900,000
| – | – |
|
193
Adobe
ADBE
$89.5B
| $9.02M | 0.14% |
+36,993
| New | +$8.75M |
|
194
Ferrari
RACE
$63.3B
| $8.89M | 0.13% |
+65,385
| New | +$8.6M |
|
195
TC Energy
TRP
$73.5B
| $8.89M | 0.13% |
+205,602
| New | +$8.73M |
|
196
Lockheed Martin
LMT
$134B
| $8.86M | 0.13% |
+29,983
| New | +$9.67M |
|
|
ABMD
197
DELISTED
Abiomed Inc
ABMD
| $8.82M | 0.13% |
21,569
+15,449
| +252% | +$5.6M |
|
198
PUT
SPDR Gold Trust
GLD
$131B
| $8.75M | 0.13% |
+77,500
| New | +$9.59M |
|
199
SM Energy
SM
$7.96B
| $8.74M | 0.13% |
+340,110
| New | +$7.95M |
|
200
Union Pacific
UNP
$183B
| $8.7M | 0.13% |
61,371
-9,343
| -13% | -$1.3M |
|
Similar funds
Marshall Wace's Q2 2018 Portfolio in Review
As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.
- Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
- Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
- Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
- Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
- Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
- Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
- Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.
Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.